2025-11769Notice

FDA Seeks Participants for Generic Drug Fee Renewal Talks

Published Date: 6/26/2025

Notice

Summary

The FDA is inviting patients, doctors, scientists, and others to join talks about renewing fees for generic drugs from 2028 to 2032. These fees help keep generic medicines affordable and available. If you want to join the conversation, let the FDA know soon so they can plan regular meetings and keep things moving smoothly.

No Economic Impacts Identified for this Document

Personalized for You

How does this regulation affect your finances?

Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Key Dates

Published Date
6/26/2025

Department and Agencies

Department
Independent Agency
Agency
Health and Human Services Department
Food and Drug Administration
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register